Other
ECMO
0
Pipeline Programs↗
1
Active Trials↗
0
Companies Involved↗
ECMO is an early-stage landscape with 0 programs across 0 companies.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
8
clinical trials
Completed4 · 50%
Withdrawn2 · 25%
Recruiting1 · 13%
Unknown status1 · 13%
Clinical Trials
Trial Activity
8 trials
Pharmacokinetic Alterations During ECMO
Completed·—·N/A·NCT01938079·20 enrolled
Evaluation of Early CRRT InTerventions in Patients With ECMO(ELITE)
Completed·—·Phase 4·NCT03549923·131 enrolled
Pharmacokinetic Study of Recombinant AT III in Neonates Undergoing ECMO
Withdrawn·—·Phase 4·NCT01913444
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)